{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:02:30Z","timestamp":1792252950025,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbrc.2023.149367","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T11:09:56Z","timestamp":1702120196000},"page":"149367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"693","author":[{"given":"Chan-juan","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-fang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9435-7228","authenticated-orcid":false,"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1030-0467","authenticated-orcid":false,"given":"Bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.149367_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.46234\/ccdcw2021.087","article-title":"Cardiovascular disease mortality - China, 2019","volume":"3","author":"Liu","year":"2021","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.bbrc.2023.149367_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2023.149367_bib3","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2023.149367_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149367_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2023.149367_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149367_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.7150\/thno.48153","article-title":"Endothelial Klf2-Foxp1-TGFbeta signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2023.149367_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.118.12267","article-title":"HIMF (Hypoxia-Induced mitogenic factor)-IL (Interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis","volume":"73","author":"Kumar","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2023.149367_bib9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbrc.2023.149367_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of inflammation in heart failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.bbrc.2023.149367_bib11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41419-021-04222-5","article-title":"Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2023.149367_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2967\/jnumed.119.232488","article-title":"Multimodality imaging of inflammation and ventricular remodeling in pressure-overload heart failure","volume":"61","author":"Glasenapp","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbrc.2023.149367_bib13","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca(2+)\/calmodulin-dependent protein kinase II delta signaling in cardiomyocytes are essential for adverse cardiac remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2023.149367_bib14","doi-asserted-by":"crossref","first-page":"A56","DOI":"10.1016\/j.jacc.2006.07.007","article-title":"Molecular mechanisms in heart failure","volume":"48","author":"Hilfiker-Kleiner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149367_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.cardfail.2012.07.003","article-title":"Fatigue, inflammation, and projected mortality in heart failure","volume":"18","author":"Fink","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbrc.2023.149367_bib16","first-page":"222","article-title":"The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure","volume":"67","author":"Pan","year":"2004","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.bbrc.2023.149367_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173690","article-title":"Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN\/AKT\/mTOR pathway","volume":"891","author":"Sun","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149367_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2023.149367_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200418","article-title":"CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure","volume":"219","author":"Zhang","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2023.149367_bib20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.7150\/ijbs.65802","article-title":"CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2023.149367_bib21","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2023.149367_bib22","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.149367_bib23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2023.149367_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/CM9.0000000000001828","article-title":"Astragaloside IV alleviates heart failure by modulating Nrf-2","volume":"135","author":"Feng","year":"2022","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbrc.2023.149367_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13757","article-title":"Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"45","author":"Shi","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bbrc.2023.149367_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.755653","article-title":"The mechanism actions of Astragaloside IV prevents the progression of hypertensive heart disease based on network pharmacology and experimental pharmacology","volume":"12","author":"Jing","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149367_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1742-2094-9-171","article-title":"The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis","volume":"9","author":"Ge","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrc.2023.149367_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13365","article-title":"IL1B triggers inflammatory cytokine production in bovine oviduct epithelial cells and induces neutrophil accumulation via CCL2","volume":"85","author":"Nakamura","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bbrc.2023.149367_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/PL00000301","article-title":"Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production","volume":"51","author":"Guglielmotti","year":"2002","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbrc.2023.149367_bib30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3389\/fphar.2019.01329","article-title":"Qi-Li-Qiang-Xin alleviates isoproterenol-induced myocardial injury by inhibiting excessive autophagy via activating AKT\/mTOR pathway","volume":"10","author":"Fan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149367_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.753095","article-title":"Cellular and molecular mechanism of traditional Chinese medicine on ventricular remodeling","volume":"8","author":"Zhu","year":"2021","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2023.149367_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1054\/jcaf.2002.127773","article-title":"Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure","volume":"8","author":"Frye","year":"2002","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbrc.2023.149367_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12872-021-02069-4","article-title":"Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.bbrc.2023.149367_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphar.2017.00181","article-title":"Identification of NF-kappaB as determinant of posttraumatic stress disorder and its inhibition by the Chinese herbal remedy free and easy wanderer","volume":"8","author":"Hong","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23014614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23014614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:49:18Z","timestamp":1762094958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23014614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0006291X23014614"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149367","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"149367"}}